LONDON--(BUSINESS WIRE)--Technavio has been monitoring the global ENT disorder treatment market since 2017 and the market is poised to grow by USD 2.1 billion during 2020-2024, progressing at a CAGR of over 2% during the forecast period. Request Free Sample Pages
Read the 155-page research report with TOC on "ENT Disorder Treatment Market Analysis Report by Geography (Asia, Europe, North America, and ROW), by Indication (Rhinitis, Sinusitis, Otitis media, and Tonsillitis), and Segment Forecasts, 2020-2024".
The rapid environmental deterioration resulting in several allergic conditions and advances in research on allergic disorders is anticipated to boost the growth of the market.
Factors such as rapid industrialization and growing use of chemical substances, especially in the agricultural and manufacturing industries are leading to several environmental changes. These changes have turned out to be harmful for people prone to allergic conditions, including ENT disorders such as sinusitis, rhinitis, and tonsillitis. For instance, diesel exhaust particles (DEPs) aggravates asthma, primarily due to the principle chemical components of DEPs. Similarly, people living in areas with high air pollution levels are susceptible to chronic sinus problems. Furthermore, factors such as increased fossil fuel combustion can cause allergic sensitization and airway responsiveness to allergens. As a result, the increase in incidences of ENT disorder is driving the demand for ENT disorder therapeutics, which is expected to drive market growth during the forecast period.
Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.
Major Five ENT Disorder Treatment Market Companies:
AbbVie Inc. is headquartered in the US and is engaged in the discovery, development, manufacture, and sale of a broad line of pharmaceutical products. The company offers Acarizax, which is an allergy immunotherapy tablet used for the treatment of rhinitis.
ALK-Abelló AS is headquartered in Denmark and is engaged in the discovery, development, manufacture, and sale of allergy treatment products. The company offers Grazax, which is an allergy immunotherapy used to treat rhinitis and conjunctivitis. It also provides ACARIZAX, which is a sublingual tablet, indicated for the treatment of house dust mite (HDM) allergic rhinitis.
Bayer AG is headquartered in Germany and operates under various business segments, namely Pharmaceuticals, Consumer health, Crop science, and Animal health. The company offers Claritin, which is an allergy immunotherapy that offers allergy relief and relives sinus pressure for kids and adults.
Covis Pharma BV
Covis Pharma BV is headquartered in the Netherlands and offers products through the following business segments: Respiratory and Allergy, Cardiovasciular, Gastroenterology and CNS, and Authorized Generics. The company offers ALVESCO, OMNARIS, and ZETONNA.
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. is headquartered in Switzerland and offers products through the following business segments: Pharmaceuticals and Diagnostics. The company offers Bactrim, which is a synthetic antibacterial combination product used to treat sinusitis caused due of bacterial infections.
Register for a free trial today and gain instant access to 17,000+ market research reports. Technavio's SUBSCRIPTION platform
ENT Disorder Treatment Indication Outlook (Revenue, USD Million, 2020-2024)
- Otitis media
ENT Disorder Treatment Regional Outlook (Revenue, USD Million, 2020-2024)
- North America
Technavio’s sample reports are free of charge and contain multiple sections of the report, such as the market size and forecast, drivers, challenges, trends, and more. Request a free sample report
Related Reports on Health Care include:
ENT Laser Devices Market – Global ENT Laser Devices Market by product (gas lasers and solid and semiconductor-based lasers) and geography (Asia, Europe, North America, and ROW).
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.